Coffee, caffeine, and coronary heart disease

Current Opinion in Lipidology

Volumn 18, Issue 1, 2007, Pages 13-19

  Cornelis, Marilyn C ^a   El Sohemy, Ahmed ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Caffeine; Coffee; Genetic modifiers; Heart disease

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CAFESTOL; CAFFEINE; CHOLESTEROL; CYTOCHROME P450 1A2; DITERPENE; HOMOCYSTEINE;

ANTIOXIDANT ACTIVITY; CACAO; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COFFEE; DISEASE ASSOCIATION; DRINKING; FOOD COMPOSITION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TEA;

BEVERAGES; CAFFEINE; COFFEE; CORONARY DISEASE; FOOD ANALYSIS; HUMANS; RISK ASSESSMENT;

EID: 33846176011     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3280127b04     Document Type: Review

References (62)

1. Myers MG, Basinski A. Coffee and coronary heart disease. Arch Intern Med 1992; 152:1767-1772.
2. Lopez-Garcia E, van Dam RM, Willett WC, et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 2006; 113:2045-2053. The largest prospective cohort study to examine the association between long-term habitual coffee consumption and risk of CHD. The study included 44 005 men and 84488 women with 14 and 20 years of follow-up, respectively. Coffee consumption was not associated with an increased risk of CHD in either men or women.
3. Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase risk of coronary heart disease? Results from a meta-analysis. Br Heart J 1994; 72:269-275.
4. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 1993; 4:366-374.
5. Hammar N, Anderson T, Alfredsson L, et al. Association of boiled and filtered coffee with incidence of first nonfatal myocardial infarction: the SHEEP and the VHEEP study. J Intern Med 2003; 253:653-659.
6. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006; 295:1135-1141. The first study to incorporate a genetic modifier of caffeine metabolism into the study of coffee and risk of myocardial infarction. An increased risk of myocardial infarction was observed only among individuals with a CYP1A2 genotype, which was associated with slow caffeine metabolism. This study provided strong evidence that caffeine is a major component of coffee responsible for this association.
7. Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. J Nutr 2004; 134:2381-2386.
8. Andersen LF, Jacobs DRJ, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006; 83:1039-1046.
9. Azevedo A, Barros H. Coffee and myocardial infarction: heterogeneity of an association in Portuguese men. Cardiovasc Prev Rehabil 2006; 13:268-273.
10. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr 2003; 133:3229-3232.
11. Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 1999; 53:481-487.
12. Kleemola P, Jousilahti P, Pietinen P, et al. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 2000; 160:3393-3400.
13. Spiller MA. The chemical components of coffee. In: Spiller GA, editor. Caffeine. Boca Raton: CRC Press; 1998. pp. 97-161.
14. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr 1997; 17:305-324.
15. Viani R. Composition of coffee. In: Garattini S, editor. Caffeine, coffee and health. New York: Raven Press; 1993. pp. 17-41.
16. Yanagimoto K, Ochi H, Lee KG, Shibamoto T. Antioxidative activities of fractions obtained from brewed coffee. J Agric Food Chem 2004; 52:592-596.
17. Olthof MR, Hollman PC, Katan MB. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 2001; 131:66-71.
18. Borrelli RC, Visconti A, Mennela C, et al. Chemical characterization and antioxidant properties of coffee melanoidins. J Agric Food Chem 2002; 50:6527-6533.
19. Pellegrini N, Serafini M, Colombi B, et al. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr 2003; 133:2812-2819.
20. Daglia M, Papetti A, Gregotti C, et al. In vitro antioxidant and ex vivo protective activities of green and roasted coffee. J Agric Food Chem 2000; 48:1449-1454.
21. Svilaas A, Sakhi AK, Andersen LF, et al. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 2004; 134:562-567.
22. Pulido R, Hernandez-Garcia M, Saura-Calixto F. Contribution of beverages to the intake of lipophillic and hydrophillic antioxidants in the Spanish diet. Eur J Clin Nutr 2003; 57:1275-1282.
23. Fredholm BB, Battig K, Holmen J, et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51:83-133.
24. Gilbert RM. Caffeine: overview and anthology. In: Miller SA, editor. Nutrition and behavior. Philadelphia: Franklin Institute Press; 1981. pp. 145-166.
25. Gilbert RM. Caffeine consumption. In: Spiller GA, editor. The methylxanthine beverages and foods: chemistry, consumption, and health effects. New York: Alan R Liss; 1984. pp. 185-213.
26. Ranheim T, Halvorsen B. Coffee consumption and human health: beneficial or detrimental? Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 2005; 49:274-284. This paper provides a comprehensive review of the mechanisms contributing to the cholesterol-raising effects of diterpenes present in boiled coffee.
27. Nawrot P, Jordan S, Eastwood J, et al. Effects of caffeine on human health. Food Addit Contam 2003; 20:1-30.
28. Spiller GA. Caffeine. Boca Raton: CRC Press; 1998.
29. Mandel HG. Update on caffeine consumption, disposition, and action. Food Chem Toxicol 2002; 40:1231-1234.
30. Harland BF. Caffeine and nutrition. Nutrition 2000; 16:522-526.
31. McCusker RR, Goldberger BA, Cone EJ. Caffeine content of energy drinks, carbonated sodas, and other beverages. J Anal Toxicol 2006; 30:112-114.
32. Shlonsky AK, Klatsky AL, Armstrong MA. Traits of persons who drink decaffeinated coffee. Ann Epidemiol 2003; 13:273-279.
33. Brown J, Kreiger N, Darlington GA, Sloan M. Misclassification of exposure: coffee as a surrogate for caffeine intake. Am J Epidemiol 2001; 153:815-820.
34. Jacobsen BK, Thelle DS. The Tromso Heart Study: is coffee drinking an indicator of a life style with high risk for ischemic heart disease? Acta Med Scand 1987; 222:215-221.
35. Schreiber GB, Robins M, Maffeo CE, et al. Confounders contributing to the reported association of coffee or caffeine with disease. Prev Med 1988; 17:295-309.
36. James JE. Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously. Psychosom Med 2004; 66:63-71.
37. LaCroix AZ, Mead LA, Liang KY, et al. Coffee consumption and the incidence of coronary heart disease. N Engl J Med 1986; 315:977-982.
38. Stensvold I, Tverdal A, Jacobsen BK. Cohort study of coffee intake and death from coronary heart disease over 12 years. BMJ 1996; 312:544-545.
39. Selb Semerl J, Selb K. Coffee and alcohol consumption as triggering factors for sudden cardiac death: case-crossover study. Croat Med J 2004; 45:775-780.
40. Baylin A, Hernandez-Diaz S, Kabagambe E, et al. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology 2006; 17:506-511. This case-crossover study suggested that coffee consumption may act as a trigger for a cardiovascular event, providing further evidence that the effects of coffee on CHD might be acute. The odds ratio of nonfatal myocardial infarction in the hour after consuming coffee was 1.49 (95% confidence interval, 1.17-1.89). The association was particularly strong among individuals who did not habitually consume more than 1 cup of coffee per day, had sedentary lifestyles, or had three or more risk factors for CHD.
41. Nurminen M, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr 1999; 53:831-839.
42. Noordzij M, Uiterwaal CS, Arends LR, et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized trials. J Hypertens 2005; 23:921-928. This is the most recent meta-analysis of controlled trials examining the blood pressure response to chronic coffee or caffeine intake. It included 16 randomized control trials (n = 1010) with treatments lasting more than 7 days. Systolic and diastolic blood pressure increased by 4.16 and 2.14 mmHg for caffeine pills and 1.22 and 0.49 mmHg for coffee, respectively. These differences could not be explained by caffeine dose, suggesting that other components of coffee are attenuating the pressor effects of caffeine. Overall, blood pressure effects were larger in trials in which more than 50% of subjects were men and boiled coffee was consumed. Hypertension status, age, and habitual coffee intake were not related to blood pressure response.
43. Hamer M. Coffee and health: explaining conflicting results in hypertension. J Hum Hypertens 2006 [Epub ahead of print]. An excellent commentary discussing potential factors contributing to the inconsistent findings of studies examining the association between coffee or caffeine and hypertension.
44. Winkelmayer WC, Stampfer M, Willett WC, Curhan GC. Habitual caffeine intake and the risk of hypertension in women. JAMA 2005; 294:2330-2335. The largest prospective cohort study to examine the association between caffeine intake and incident hypertension. This study included 155 594 US women followed up over 12 years. An inverse U-shaped association between caffeine consumption and hypertension was found. When studying individual classes of caffeinated beverages, consumption of sugared or diet cola, but not coffee, was associated with an increased risk of hypertension, suggesting that something in coffee other than caffeine might be protective.
45. Jee SH, He J, Appel LJ, et al. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001; 153:353-362.
46. Husemoen LL, Thomsen TF, Fenger M, Jorgensen T. Effect of lifestyle factors on plasma total homocysteine concentrations in relation to MTHFR (C677T) genotype. Inter99 (7). Eur J Clin Nutr 2004; 58:1142-1150.
47. Verhoef P, Pasman WJ, van Vliet T, et al. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized trial in humans. Am J Clin Nutr 2002; 76:1244-1248.
48. Strandhagen E, Zetterberg H, Aires N, et al. The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study. Int J Mol Med 2004; 13:811-815.
49. Olthof MR, Hollman PC, Zock PL, Katan MB. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr 2001; 73:532-538.
50. Zampelas A, Panagiotakos DB, Pitsavos C, et al. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 2004; 80:862-867.
51. Tsioufis C, Dimitriadis K, Vasiliadou C, et al. Heavy coffee consumption in conjunction with smoking is accompanied by increased inflammatory processes and impaired thrombosis/fibrinolysis system in essential hypertensive subjects. J Hum Hypertens 2006; 20:470-472.
52. Yukawa GS, Mune M, Otani H, et al. Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans. Biochemistry 2004; 69:70-74.
53. Esposito F, Morisco F, Verde V, Ritieni A. Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Aliment Pharmacol Ther 2003; 17:595-601.
54. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005; 294:97-104. An excellent systematic review supporting the hypothesis that habitual coffee consumption is associated with a substantially lower risk of type 2 diabetes. Based on data from nine cohort studies, the summary relative risk of type 2 diabetes was 0.65 (95% confidence interval, 0.54-0.78) for 6 or more cups of coffee per day and 0.72 (0.62-0.83) for 4-6 cups per day compared with 2 or fewer cups per day. This review also discusses potential mechanisms mediating this association.
55. van Dam RM. Coffee and type 2 diabetes: from beans to beta-cells. Nutr Metab Cardiovasc Dis 2006; 16:69-77.
56. Weggemans RM, Zock PL, Ordovas JM, et al. Apoprotein E genotype and the response of serum cholesterol to dietary fat, cholesterol and cafestol. Atherosclerosis 2001; 154:547-555.
57. Weggemans RM, Zock PL, Ordovas JM, et al. Genetic polymorphisms and lipid response to dietary changes in humans. Eur J Clin Invest 2001; 31:950-957.
58. Strandhagen E, Zetterberg H, Aires N, et al. The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee. Lipids Health Dis 2004; 3:26-31.
59. Gu L, Gonzalez FJ, Kalow W, Tang BK. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 1992; 2:73-77.
60. Tantcheva-Poor I, Ziegler M, Rietbrock S, Fuhr U. Estimation of cytochrome P-450 CYP1A2 activity in 63 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 1999; 9:131-144.
61. Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C to A polymorphismin intron 1 of the cytochrome P450 1A2 (CYP1A2) gene tested with caffeine. Br J Clin Pharmacol 1999; 47:445-449.
62. Breinholt VM, Offord EA, Brouwer C, et al. In vitro investigation of cytochrome p450-mediated metabolism of dietary flavonoids. Food Chem Toxicol 2002; 40:609-616.